Dr. Puna Maya Maharjan is a senior scientist at G+FLAS Life Sciences, Republic of Korea. She is conducting research on plant-derived biopharmaceuticals, including vaccines for influenza and COVID-19. She completed her Ph.D. in biological sciences in 2013 at Seoul National University, Seoul, Korea. She obtained post-doctoral experience in plant biology for over five years at the Plant Genomics and Breeding Institute (PGBI), Institute of Basic Sciences (IBS, Korea), and Brain Korea 21 (BK21) at Seoul National University, Korea. She earned her Master’s degree in Botany at the Central Department of Botany, Tribhuvan University, in 2005. She was awarded the “Future Scientist Award 2012” by the Korean Society of Plant Biologists. Since her Ph.D., she has been working in plant biotechnology, plant hormone interactions, CRISPR-based plant genome editing, and plant-based vaccine and biopharmaceuticals production. She has two patents registered related to her research findings.